Page 134 - The Indian Optician Digital Edition March-April 2024
P. 134
ANTI-VEGF INJECTIONS
INJECTIONS CONTAIN
SPECIALISED DRUGS THAT
BIND TO VEGF RECEPTORS,
ESSENTIALLY BLOCKING VEGF'S
ABILITY TO WREAK HAVOC
Optical Coherence Tomography (OCT)
Scans: This imaging technique provides a
detailed cross-sectional view of the retina,
allowing the ophthalmologist to monitor FIGURE 11 - OPTICAL COHERENCE TOMOGRAPHY (OCT)
changes in fluid accumulation and overall
retinal health. of retinal disease, optometrists can promptly
Intraocular Pressure Monitoring: A potential refer patients to ophthalmologists for further
side effect of some anti-VEGF agents is an evaluation and potential treatment with anti-
increase in intraocular pressure. Regular VEGF injections. This collaborative approach
monitoring allows for early detection and between optometrists and ophthalmologists
intervention if necessary. ensures patients receive timely and effective
treatment.
A COLLABORATIVE APPROACH:
OPTOMETRISTS AS PARTNERS IN REFERENCES
VISION CARE 1. Rosenfeld PJ, Brown DM, Heier JS, et al.
Ranibizumab for neovascular age-related macular
Optometrists play a vital role in the fight degeneration. N Engl J Med. 2006;355(14):1419-1431.
against retinal diseases. Often the first point doi:10.1056/NEJMoa054481
of contact for patients experiencing vision 2. Nguyen QD, Brown DM, Marcus DM, et al.
problems, they can play a crucial role in Ranibizumab for diabetic macular edema: results
early detection through comprehensive eye from 2 phase III randomised trials: RISE and RIDE.
examinations. By recognising the early signs Ophthalmology. 2012;119(4):789-801. doi:10.1016/j.
ophtha.2011.12.039
3. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP,
Ianchulev T; ANCHOR Study Group. Ranibizumab
versus verteporfin photodynamic therapy for
neovascular age-related macular degeneration:
two-year results of the ANCHOR study.
Ophthalmology. 2009;116(1):57-65.e5. doi:10.1016/j.
ophtha.2008.10.018
4. Wells JA, Glassman AR, Ayala AR, et al; Diabetic
Retinopathy Clinical Research Network.
Aflibercept, bevacizumab, or ranibizumab
for diabetic macular edema. N Engl J Med.
2015;372(13):1193-1203. doi:10.1056/NEJMoa1414264
5. Campochiaro PA, Heier JS, Feiner L, et al.
Ranibizumab for macular edema following
branch retinal vein occlusion: six-month
primary end point results of a phase III study.
Ophthalmology. 2010;117(6):1102-1112.e1. doi:10.1016/j.
ophtha.2010.02.021
130 | THE INDIAN OPTICIAN | MAR-APR 2024 CLINICAL
